Meta‐long Papyrus: Meta‐analysis of mid to long‐term outcomes of PK Papyrus covered stent
Catheterization and Cardiovascular Interventions · 2024-09 · 104 (3) · 492-498
DOI: 10.1002/ccd.31157 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 20.07.2024. Verfasst von Alfonso Jurado-Román und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, La Paz University Hospital, Madrid, Spain. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Prosthesis Design, Stents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Biotronik.
Abstract (Originalsprache)
Background
Although covered stents (CS) represent a potentially life‐saving intervention for coronary perforation (CAP), their application has expanded to other contexts, including coronary aneurysms (CAA). However, data regarding mid‐ and long‐term outcomes of CS in these settings scenarios remains limited.
Aims
This meta‐analysis aims to evaluate major adverse cardiac events (MACE) from discharge through long‐term follow‐up in patients undergoing percutaneous coronary intervention with the new generation polyurethane‐covered cobalt‐chromium PK Papyrus CS.
Methods
We conducted a meta‐analysis of data from three observational trials that included long‐term follow‐up of patients who underwent PK Papyrus CS implantation: Papyrus‐Spain, SOS PK Papyrus, and PAST‐PERF registry.
Results
332 patients underwent PK Papyrus CS implantation, 236 (71.1%) for CAP, 70 (21.1%) for CAA and 26 (7.8%) for other indications. After a mean follow‐up of 16.2 months, the MACE was 14.3%, with Target Lesion Revascularization (TLR) being the most frequent (8.5%), followed by stent thrombosis (ST), 3.3% and cardiac death (CD), 2.6%. Comparing CAP and CAA subgroups, the MACE rate in CAA was significantly higher than CAP (21.4% vs 9.7%, p < 0.01), primary driven by ST (CAA: 8.6% vs CAP: 1.3%; p = 0.0015).
Conclusions
The clinical outcomes following PK Papyrus CS implantation are deemed acceptable, considering the challenging scenarios and the existing alternative treatments. However, MACE rates in patients with CAA who received Papyrus PK CS were significantly higher than in those with CAP, underscoring the importance of meticulous patient selection and optimization of CS in these complex patients and coronary anatomies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology Department, La Paz University Hospital, Madrid, Spain.
- Hospital La Paz Institute for Health Research, IdiPAZ, Madrid, Spain.
- Cardiology department, Catalunya General University Hospital, Barcelona, Spain.
- Herzklinik Ulm, Ulm, Germany.
- Institut del Cor, Germans Trias i Pujol University Hospital, Barcelona, Spain.
- Cardiology Department, Hospital Of Annecy, Cannes, France.
ORCID-Profile: Alfonso Jurado-Román, Daniel Tébar-Márquez, Raúl Moreno
Förderung
- Biotronik
Zitieren
APA
Jurado-Román, A., Tébar-Márquez, D., Hernandez-Enríquez, M., Birkemeyer, R., Rodríguez-Leor, O., Spinu, R., Belle, L., Galeote, G., Jiménez-Valero, S., & Moreno, R. (2024). Meta‐long Papyrus: Meta‐analysis of mid to long‐term outcomes of PK Papyrus covered stent. Catheterization and Cardiovascular Interventions, 104(3), 492-498. https://doi.org/10.1002/ccd.31157
Vancouver
Jurado-Román A, Tébar-Márquez D, Hernandez-Enríquez M, Birkemeyer R, Rodríguez-Leor O, Spinu R, et al. Meta‐long Papyrus: Meta‐analysis of mid to long‐term outcomes of PK Papyrus covered stent. Catheterization and Cardiovascular Interventions. 2024;104(3):492-498. doi:10.1002/ccd.31157
BibTeX
@article{JuradoRomn2024,
author = {Jurado-Román, Alfonso and Tébar-Márquez, Daniel and Hernandez-Enríquez, Marco and Birkemeyer, Ralf and Rodríguez-Leor, Oriol and Spinu, Radu and Belle, Loïc and Galeote, Guillermo and Jiménez-Valero, Santiago and Moreno, Raúl},
title = {Meta‐long Papyrus: Meta‐analysis of mid to long‐term outcomes of PK Papyrus covered stent},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
volume = {104},
number = {3},
pages = {492--498},
doi = {10.1002/ccd.31157}
}
EUVIMED